PENNINGTON, N.J. and SAN DIEGO, May 13, 2020 /PRNewswire/ -- OncoSec Medical Incorporated (Nasdaq:ONCS) (the "Company" or "OncoSec"), a company developing late-stage intratumoral cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback